Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet

Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet

The company hopes that the easy accessibility and affordable price point of an effective treatment such as Favivent will offer Indian citizens a timely, much-needed therapeutic solution

Drug firm Jenburkt Pharmaceuticals on Friday said it has launched antiviral drug Favipiravir under the brand name 'Favivent' for the treatment of mild to moderate Covid-19 symptoms at a price of Rs 39 per tablet.

The tablet will be available in 200 mg strength in the form of a strip of 10 tablets, it added.

The drug will be manufactured at a pharmaceutical plant in Telangana with the highest safety and manufacturing protocols in place, Jenburkt Pharmaceuticals said in a statement.

On Thursday, pharma company Brinton Pharmaceuticals had said it will be selling Favipiravir under the brand name 'Faviton' at a maximum retail price of Rs 59 per tablet.

Pharma major Glenmark Pharmaceuticals is already selling Favipiravir under the brand name 'FabiFlu' at a price of Rs 75 per tablet.

ALSO READ: Cipla gets DCGI approval to sell Covid-19 drug favipiravir in India

Earlier this year, the Drug Controller General of India (DCGI) had approved the use of Favipiravir -- an antiviral drug developed in Japan and commonly used for treating influenza -- for the treatment of mild to moderate cases of Covid-19 in India.

"Given the current scenario of grave health concerns and economic challenges surrounding Covid-19 in India, if we as a pharmaceutical company cannot make a significant positive difference to the society, our company's very existence is inconsequential," Jenburkt Pharmaceuticals Chairman and MDAshish U Bhuta said.

The company hopes that the easy accessibility and affordable price point of an effective treatment such as Favivent will offer Indian citizens a timely, much-needed therapeutic solution, he added.

Shares of Jenburkt Pharmaceuticals closed at Rs 391.90per scrip on BSE, down 1.05 per cent.

  • Jenburkt Pharma launches COVID-19 drug at Rs 39 per tablet

    View
  • Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet

    View
  • Jenburkt Pharma Launches Antiviral Covid-19 Drug Favipiravir Priced at Rs 39 Per Tablet

    View
  • Jenburkt Pharma launches COVID-19 drug at Rs 39 per tablet

    View
  • Jenburkt Pharma launches COVID-19 drug at Rs 39 per tablet

    View
  • Coronavirus Cases in India Cross 15 Lakh-Mark After 48,513 People Test Positive in Past 24 Hours, COVID-19 Death Toll Mounts to 34,193

    View
  • Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19

    View